Late-post-COVID-19 cerebral venous sinus thrombosis and stroke: a case report.


Journal

Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752

Informations de publication

Date de publication:
01 01 2023
Historique:
pubmed: 28 12 2022
medline: 30 12 2022
entrez: 27 12 2022
Statut: ppublish

Résumé

Coronavirus disease 2019 (COVID-19) disease increases risk of venous thromboembolisms (VTE), primarily deep vein thrombosis and pulmonary embolism. Only a few cases of cerebral venous sinus thrombosis (CVST) in association with a COVID-19 infection have been reported and are limited to acute COVID-19 disease. Hypercoagulable conditions persist in postacute COVID-19 disease, which carries an increased risk of VTE. We report a case of CVST and stroke 56 days post-COVID-19 infection presenting with an atypical clinical picture. To the best of our knowledge, this is one of the first observations of CVST in the postacute phase of COVID-19 disease. Clinicians should be aware of this potential late complication and should consider appropriate diagnostic imaging techniques in patients with COVID-19-infection history.

Identifiants

pubmed: 36574302
doi: 10.2459/JCM.0000000000001400
pii: 01244665-202301000-00012
pmc: PMC9793994
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

72-74

Informations de copyright

Copyright © 2022 Italian Federation of Cardiology - I.F.C. All rights reserved.

Références

Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Müller MCA, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost 2020; 18:1995–2002.
Battistoni I, Francioni M, Morici N, Rubboli A, Podda GM, Pappalardo A, et al. Preand in-hospital anticoagulation therapy in coronavirus disease 2019 patients: a propensity-matched analysis of in-hospital outcomes. J Cardiovasc Med (Hagerstown) 2022; 23:264–271.
Thompson A, Morgan C, Smith P, Jones C, Ball H, Coulthard EJ, et al. Cerebral venous sinus thrombosis associated with COVID-19. Pract Neurol 2021; 21:75–76.
Mowla A, Shakibajahromi B, Shahjouei S, Borhani-Haghighi A, Rahimian N, Baharvahdat H, et al. Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series. J Neurol Sci 2020; 15:117183.
Dakay K, Cooper J, Bloomfield J, Overby P, Mayer SA, Nuoman R, et al. Cerebral venous sinus thrombosis in COVID-19 infection: a case series and review of the literature. J Stroke Cerebrovasc Dis 2021; 30:105434.
Abdalkader M, Shaikh SP, Siegler JE, Cervantes-Arslanian AM, Tiu C, Radu RA, et al. Cerebral venous sinus thrombosis in COVID-19 patients: a multicenter study and review of literature. J Stroke Cerebrovasc Dis 2021; 30:105733.
Loos CMJ, Yperzeele L, Jadoul C, Baar I, Jorens PG. Deep cerebral venous sinus thrombosis with transient antiphospholipid antibodies in COVID-19 disease. Acta Neurol Belg 2021; 121:291–293.
Kaur I, Vyas C, Mughal M, Gandhi H, Du D. Cerebral venous sinus thrombosis in COVID-19: an unusual presentation. Cureus 2021; 13:e13767.
Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. Am J Hematol 2020; 95:1578–1589.
Zhang Y, Coats AJS, Zheng Z, Adamo M, Ambrosio G, Anker SD, et al. Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020; 22:941–956.
Lambadiari V, Mitrakou A, Kountouri A, Thymis J, Katogiannis K, Korakas E, et al. Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection. Eur J Heart Fail 2021; 23:1916–1926.
Inama G, Dodi C, Provini M, Bossoni E, Inama L, Balzarini L, et al. Coronavirus disease 2019 infection in patients with recent cardiac surgery: does chronic anticoagulant therapy have a protective effect? J Cardiovasc Med (Hagerstown) 2020; 21:765–771.
Idiculla PS, Gurala D, Palanisamy M, Vijayakumar R, Dhandapani S, Nagarajan E. Cerebral venous thrombosis: a comprehensive review. Eur Neurol 2020; 83:369–379.
Kenmuir CL, Jovin T, Jadhav A. Cerebral venous sinus thrombosis in users of a hormonal vaginal ring. Obstet Gynecol 2015; 126:830–833.
Arcari L, Luciani M, Cacciotti L, Pucci M, Musumeci MB, Pietropaolo L, et al. Coronavirus disease 2019 in patients with cardiovascular disease: clinical features and implications on cardiac biomarkers assessment. J Cardiovasc Med (Hagerstown) 2021; 22:832–839.
Perry RJ, Tamborska A, Singh B, Craven B, Marigold R, Arthur-Farraj P, et al. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. Lancet 2021; 398:1147–1156.

Auteurs

Nino Cmor (N)

Division of Cardiology.

Eva Dora (E)

Division of Cardiology.

Darko Rajtman (D)

Division of Cardiology.

Miha Tibaut (M)

Division of Cardiology.

Sabina Horvat (S)

Division of Neurology, General Hospital Murska Sobota, Murska Sobota.

Janja Zver (J)

Department of Radiology, Institute of Oncology, Ljubljana, Slovenia.
Department of Radiology, General Hospital Murska Sobota, Murska Sobota.

Mitja Lainscak (M)

Division of Cardiology.
Faculty of Medicine, University of Ljubljana, Ljubljana.
Faculty of Natural Sciences and Mathematics, University of Maribor, Maribor, Slovenia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH